News

ALLG welcomes the release of the Health Technology Assessment (HTA) Review by the Albanese Government.

We support the implementation strategy for the HTA Review Report and the 50 recommendations from the expert Reference Committee panel for reforms to improve systems and pathways to accelerate access to new medicines for Australians.

During the two years of the HTA Report’s development, ALLG and our members provided strong and regular contributions to the consultation process.

ALLG and our members are committed to pursuing Better treatments, better lives for patients with blood cancers. The ALLG is committed to ensuring our clinical trial results translate to evidence-based care with timely approvals of new, safe medicines.

Better and faster access to the best therapies and drugs for patients is vital in achieving these goals.

ALLG CEO Delaine Smith said, “Transparency to the policy and procedures for triaging HTA review will be key to ensure public, consumer and health professional confidence.”

“The ALLG has advocated throughout the consultation process for the adoption of methods that will achieve outcomes in a timely manner and for a fair review process.”

“We are optimistic about the future and look forward to strong engagement in the implementation plans.”

The HTA Review Report is available to read at the health.gov.au website.